Title : Effectiveness of triple therapy with simeprevir for chronic hepatitis C genotype 1b patients with prior telaprevir failure.

Pub. Date : 2015 Dec

PMID : 26075320






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Favourable efficacy and safety profiles for simeprevir in combination with pegylated interferon alpha (PEG-IFNalpha) and ribavirin (triple therapy) have been shown in clinical trials. Simeprevir interferon alpha 1 Homo sapiens
2 The treatment outcome of simeprevir-based triple therapy for HCV genotype 1b patients with prior telaprevir failure depended on the prior response to PEG-IFNalpha and ribavirin. Simeprevir interferon alpha 1 Homo sapiens